Tech Company Financing Transactions

Juvaris BioTherapeutics Funding Round

Kleiner Perkins Caufield & Byers, SV Health Investors and private investors participated in a $25 million Series B venture round for Juvaris BioTherapeutics. The round was announced by the company on 1/27/2010.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

P.O. Box 208
Pleasanton, CA 94566
USA

Phone

(650) 259-1800

Website

www.juvaris.com

Email Address

[email protected]

Overview

Juvaris BioTherapeutics is a new biotechnology company, started in February, 2003, that is developing potent active immunotherapeutic vaccines. Active immunotherapy involves the activation of the patient's own immune system to combat disease as opposed to passive immunotherapy utilizing administration of preformed monoclonal antibodies.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Grant Pickering

        

Chief Financial Officer

Kimberlee Gonzaga

        

Browse more venture capital transactions:

Prev: 1/26/2010: ReachForce venture capital transaction
Next: 1/27/2010: CampaignerCRM venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary